Valuation: Smith & Nephew Plc

Market Cap 12.25B 10.5B 9.84B 8.98B 16.95B 1,168B 17.12B 116B 45.16B 589B 45.99B 44.99B 1,951B P/E 2026 *
18.3x
P/E 2027 * 15.3x
Enterprise Value 15.1B 12.94B 12.12B 11.07B 20.9B 1,439B 21.1B 143B 55.66B 726B 56.69B 55.45B 2,405B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.17x
Free-Float
99.55%
Yield 2026 *
2.8%
Yield 2027 * 3.01%
1 day-0.39%
1 week-3.08%
Current month-10.64%
1 month-7.35%
3 months-5.97%
6 months-17.78%
Current year-10.19%
1 week 12.4
Extreme 12.4
12.7
1 month 12.4
Extreme 12.4
14.2
Current year 12.3
Extreme 12.3
15.84
1 year 12.3
Extreme 12.3
16.64
3 years 10.21
Extreme 10.21
16.64
5 years 10.21
Extreme 10.21
16.64
10 years 10.21
Extreme 10.21
24.2
Manager TitleAgeSince
Chief Executive Officer 54 2022-03-31
Director of Finance/CFO 58 2024-03-31
Chief Tech/Sci/R&D Officer 59 2016-07-31
Director TitleAgeSince
Director/Board Member 67 2017-09-30
Director/Board Member 62 2020-10-31
Director/Board Member 64 2021-02-16
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-3.08% - - 12.25B
+0.24%-2.23%-15.70%+19.44% 127B
+0.54%+0.31%-22.33%-0.11% 12.25B
-0.62%-4.98%+92.04%+143.33% 10.69B
+2.13%-4.21%-51.63%-68.92% 4.19B
+0.57%+4.02%-22.01%+58.76% 2.78B
-0.23%-1.22%-33.58%-72.13% 1.77B
+1.12%-0.84%-23.32%-12.99% 1.64B
+0.47%-3.59%-36.96%-38.68% 1.57B
Average +0.42%+0.45%-14.19%+3.59% 20.21B
Weighted average by Cap. +0.25%-0.46%-10.60%+22.65%

Financials

2026 *2027 *
Net sales 6.48B 5.55B 5.2B 4.75B 8.97B 618B 9.06B 61.38B 23.9B 312B 24.33B 23.8B 1,032B 6.84B 5.86B 5.49B 5.02B 9.47B 652B 9.56B 64.78B 25.22B 329B 25.68B 25.12B 1,089B
Net income 686M 588M 551M 503M 949M 65.37B 958M 6.49B 2.53B 32.98B 2.57B 2.52B 109B 813M 697M 653M 597M 1.13B 77.54B 1.14B 7.7B 3B 39.12B 3.05B 2.99B 130B
Net Debt 2.85B 2.44B 2.29B 2.09B 3.94B 271B 3.98B 26.97B 10.5B 137B 10.69B 10.46B 454B 2.56B 2.2B 2.06B 1.88B 3.55B 244B 3.58B 24.28B 9.45B 123B 9.63B 9.42B 408B
Logo Smith & Nephew Plc
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.5%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.4%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (29.1%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.6% of net sales.
Employees
17,000
Date Price Change
26-08-26 12.60 -0.79%
26-08-25 €12.70 +1.60%
26-08-24 €12.50 +0.81%
26-08-21 €12.40 -0.80%
26-08-20 €12.50 -3.85%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
14.56USD
Average target price
17.44USD
Spread / Average Target
+19.79%

Quarterly revenue - Rate of surprise